TIL
Instil Bio Inc.NASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$53.78M
P/E Ratio
—
EPS
$-7.00
Beta
1.91
52W High
$35.00
52W Low
$5.67
50-Day MA
$8.17
200-Day MA
$12.20
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Instil Bio Inc.
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer patients. The company is headquartered in Dallas, Texas.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 138,000 |
| EBITDA | $-44.40M |
| Operating Margin | 0.00% |
| Return on Equity | -37.10% |
| Return on Assets | -12.70% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $16.79 |
| Price-to-Book | 0.49 |
| Price-to-Sales (TTM) | 54248.82 |
| EV/Revenue | 43213.95 |
| EV/EBITDA | 0.62 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $6.78M |
| Float | $3.62M |
| % Insiders | 6.29% |
| % Institutions | 62.20% |
Historical Volatility
HV 10-Day
12.11%
HV 20-Day
12.09%
HV 30-Day
13.80%
HV 60-Day
32.85%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($7.00 target)
2
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026